• Thor Medical scrapped its planned subsequent offering of up to 9,400,000 new shares priced at NOK 4.8 each.
• The decision followed trading in the stock at prices close to or below NOK 4.8 since the NOK 300 million private placement.
• The company said shareholders seeking to offset dilution have been able to buy shares in the market at similar or lower prices.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Thor Medical ASA published the original content used to generate this news brief via NewsWeb, the disclosure sustem operated by Euronext Oslo (Ref. ID: 202609220130OSLOBORSNEWS__EN_479ECE4239DF18AFEDD0CB7A2829B79), on September 22, 2026, and is solely responsible for the information contained therein.